|Author:||Stavros Manolagas,Jerrold Olefsky|
|Title:||Metabolic Bone and Mineral Disorders (Contemporary Issues in Endocrinology and Metabolism)|
|Format:||doc lit docx azw|
|ePUB size:||1581 kb|
|FB2 size:||1767 kb|
|DJVU size:||1940 kb|
|Publisher:||Churchill Livingstone; Unabridged. edition (September 1, 1988)|
Special attention has been given to the problem of osteoporosis. Library descriptions. No library descriptions found.
Published 1988 by Churchill Livingstone in New York. Includes bibliographies and index. Contemporary issues in endocrinology and metabolism ;, v. 5. Classifications.
Bioengineering UC Berkeley San Francisco, California, USA Stavros C. Manolagas, MD, PhD Division of Endocrinology and Metabolism Center for Osteoporosis and Metabolic Bone Diseases University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System Little Rock, Arkansas, USA Joan C. Marini, MD, PhD National Institute of Child Health and Human Development Bone and Extracellular Matrix Branch National Institutes of Health.
This book gives an excellent overview of abnormalities in growth. The second chapter reports on current basic-science studies on growth hormone and the hypothalamic releasing hormone, and the third chapter is an intorniati ve presentation ot clinical issues in growth hormone deficiency. Alterations ot growth pattern in diabetes mellitus are next examined, with mention of the effects.
New York: Raven Press, 1992: 219–40. Vet Quart 1994; 16: 50–9. Principles and Practice of Endocrinology and Metabolism. Philadelphia: JB Lippincott, 1990: 480–4. Marcus R. Endocrine control of bone and mineral metabolism. London: Churchill Livingstone, 1988: 13–31.
lism/Diabetes Mellitus. Posted by admin at 10:09 am Tagged with: lism/Diabetes Mellitus.
Other metabolic bone diseases are relatively less common, but nevertheless are a source of significant morbidity and cost to society.
Although estrogen is clearly effective in modulating bone metabolism and was routinely prescribed prior to the Women’s Health Initiative, it is a controversial supplement.